Morten L Hansen

Summary

Affiliation: Bispebjerg University Hospital
Country: Denmark

Publications

  1. doi request reprint Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations
    Fredrik Folke
    Research Fellow, Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Circulation 120:510-7. 2009
  2. doi request reprint Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    Morten L Hansen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65 2900, Hellerup, Copenhagen, Denmark
    Arch Intern Med 170:1433-41. 2010
  3. pmc Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction
    Morten L Hansen
    Department of Cardiovascular Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
    Br J Clin Pharmacol 65:217-23. 2008
  4. doi request reprint Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers
    Morten Lock Hansen
    Department of Cardiology, Bispebjerg University Hospital, Bispebjerg Bakke 23, DK 2400 Copenhagen, Denmark
    Europace 10:395-402. 2008
  5. doi request reprint Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation
    M L Hansen
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    J Intern Med 265:335-44. 2009
  6. doi request reprint Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
    Rikke Sørensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Lancet 374:1967-74. 2009
  7. pmc Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study
    Rikke Sørensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    BMC Cardiovasc Disord 10:6. 2010
  8. doi request reprint Differences between out-of-hospital cardiac arrest in residential and public locations and implications for public-access defibrillation
    Fredrik Folke
    Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark
    Circulation 122:623-30. 2010
  9. doi request reprint Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Arch Intern Med 169:141-9. 2009
  10. doi request reprint Clarithromycin use and risk of death in patients with ischemic heart disease
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark
    Cardiology 116:89-97. 2010

Detail Information

Publications17

  1. doi request reprint Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations
    Fredrik Folke
    Research Fellow, Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Circulation 120:510-7. 2009
    ..The potential benefit and economic consequences of focused or unfocused AED deployment are unknown...
  2. doi request reprint Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    Morten L Hansen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65 2900, Hellerup, Copenhagen, Denmark
    Arch Intern Med 170:1433-41. 2010
    ..Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy...
  3. pmc Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction
    Morten L Hansen
    Department of Cardiovascular Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
    Br J Clin Pharmacol 65:217-23. 2008
    ..Therefore, for long-term benefits for patients who need treatment with an ACE inhibitor, a focus of treatment at the recommended dosage is most important and not which ACE inhibitor is used...
  4. doi request reprint Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers
    Morten Lock Hansen
    Department of Cardiology, Bispebjerg University Hospital, Bispebjerg Bakke 23, DK 2400 Copenhagen, Denmark
    Europace 10:395-402. 2008
    ..To study evolvement in pharmacotherapy of atrial fibrillation from 1995 to 2004...
  5. doi request reprint Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation
    M L Hansen
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    J Intern Med 265:335-44. 2009
    ..To analyse how hospital factors influence the use of oral anticoagulants (OAC) in atrial fibrillation (AF) patients and address the clinical consequences of hospital variation in OAC use...
  6. doi request reprint Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
    Rikke Sørensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Lancet 374:1967-74. 2009
    ..However, data for the safety of combinations are sparse. We examined the risk of hospital admission for bleeding associated with different antithrombotic regimens...
  7. pmc Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study
    Rikke Sørensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    BMC Cardiovasc Disord 10:6. 2010
    ..We studied the risk of death or recurrent myocardial infarction (MI) in relation to 6- and 12-months clopidogrel treatment among MI patients treated with PCI...
  8. doi request reprint Differences between out-of-hospital cardiac arrest in residential and public locations and implications for public-access defibrillation
    Fredrik Folke
    Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark
    Circulation 122:623-30. 2010
    ..We examined whether residential OHCA areas suitable for placement of automated external defibrillators could be identified on the basis of demographic characteristics and characterized individuals with OHCA in residential locations...
  9. doi request reprint Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Arch Intern Med 169:141-9. 2009
    ..We studied the risk of death and hospitalization because of acute myocardial infarction and heart failure (HF) associated with use of NSAIDs in an unselected cohort of patients with HF...
  10. doi request reprint Clarithromycin use and risk of death in patients with ischemic heart disease
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte Hospital, Copenhagen, Denmark
    Cardiology 116:89-97. 2010
    ..To examine whether treatment with clarithromycin was associated with an increased risk of death in patients with preexisting ischemic heart disease (IHD)...
  11. doi request reprint Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease
    Jakob Raunsø
    Department of Cardiology, Gentofte Hospital, Copenhagen University Hospital, Post 67, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Eur J Heart Fail 12:692-7. 2010
    ..In the present study, we investigated the prognostic impact of AF in a large population with HF of various aetiologies...
  12. doi request reprint Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circ Heart Fail 2:582-90. 2009
    ..Guidelines recommend use of selective serotonin reuptake inhibitors (SSRIs), but knowledge of the prognostic effect of different classes of antidepressants is sparse...
  13. doi request reprint Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Hellerup, Copenhagen DK 2900, Denmark
    Europace 11:886-91. 2009
    ..To examine the risk of death associated with antiarrhythmic drug (AAD) therapy in a nationwide unselected cohort of patients with atrial fibrillation (AF)...
  14. doi request reprint Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Copenhagen, Denmark
    Cardiology 112:144-50. 2009
    ..To study differences in the clinical efficacy of various brands of beta-blocker in secondary prevention after a myocardial infarction (MI)...
  15. doi request reprint The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Pharmacoepidemiol Drug Saf 17:822-33. 2008
    ..To describe the nationwide pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in the Danish population...
  16. doi request reprint Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people
    Tina Ken Schramm
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, DK 2900, Hellerup, Denmark
    Circulation 117:1945-54. 2008
    ..Previous studies reveal major differences in the estimated cardiovascular risk in diabetes mellitus, including uncertainty about the risk in young patients. Therefore, large studies of well-defined populations are needed...
  17. ncbi request reprint Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circulation 116:737-44. 2007
    ..We studied initiation and persistence of evidence-based pharmacotherapy in 107,092 patients discharged after first hospitalization for heart failure in Denmark from 1995 to 2004...